In the last decade, active surveillance (AS) has emerged as an acceptable choice for low-
risk prostate cancer (PC), however there is discordance amongst large AS cohort studies …

Author links open overlay panel F. Rozet ab, C. Hennequin ac, J.-B. Beauval ad, P.
Beuzeboc ae, L. Cormier af, G. Fromont-Hankard ag, P. Mongiat-Artus ah, G. Ploussard ai …

Active surveillance (AS) represents a well-recognized management option for many patients
with low-and very low-risk prostate cancer (PCa). AS aims to reduce overtreatment whilst …

Purpose: The prospective PCM301 trial randomized 413 men with low risk prostate cancer
to partial gland ablation with vascular targeted photodynamic therapy in 207 and active …

Rationale and Objectives Prostate volume (PV) determination provides important clinical
information. We compared PVs determined by digital rectal examination (DRE), transrectal …

Background: Inaccurate risk classification and the burden of unnecessary biopsies are a
challenge due to the limited ability of current risk assessment tools and modalities to …

The primary goal of active surveillance (AS) is to prevent overtreatment by selecting patients
with low-risk prostate cancer (PCa) and closely monitoring them so that definitive treatment …

Background Active surveillance (AS) for low-risk prostate cancer (PCa) appears to provide
excellent long-term PCa-specific and overall survival. The choice for AS as initial treatment …

Background: Active surveillance (AS) is increasingly accepted for managing low-risk
prostate cancer, yet there is no consensus about implementation. This lack of consensus is …

Purpose Recent NCCN®(National Comprehensive Cancer Network®) Guidelines® show
that patients with biopsy Gleason score 3+ 4/Grade Group 2 but otherwise favorable features …